The role of cannabinoid receptor involvement in our ARDS model, is consistent with the observation that CB1 and CB2 receptors are expressed in the lungs and the bronchial tissue (Turcotte et al., 2016). Here, CNR1 is linked to acute respiratory distress syndrome.